OSI Pharmaceuticals, Inc. (NASDAQ:OSIP.DL)

CAPS Rating: No stars

A mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top OSIP.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NetscribeBiotech (95.36)
Submitted May 28, 2007

OSI pharmaceutical is looking to position itself as a specialty player in the oncology market through its drug Tarceva, which has booked global sales worth $650 million in 2006 alone. The company’s partnership with Genetech and Roche to market… More

esebeus (44.84)
Submitted February 03, 2007

Once Tarceva becomes obsolete around 2009, this stock is junk. Bad mgmt. Poor upside.

OSIP.DL VS S&P 500 (SPY)

OSIP.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about OSIP.DL.

No one has written a Pitch for OSIP.DL stock yet. Tell us why you think OSIP.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in OSIP.DL.

No players have picked OSIP.DL yet. Tell us why you think OSIP.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRBCCapMkts 88.58 7/13/2009 Outperform NS $30.59 +87.94% +20.73% +67.20 6/9/2010 @ $57.49 0 Comment
TrackCanaccord 40.38 2/20/2009 Outperform NS $40.40 +39.78% +46.03% -6.25 3/2/2010 @ $56.47 0 Comment
TrackLeerinkSwan 95.46 2/20/2009 Outperform NS $38.68 +48.63% +38.95% +9.68 6/9/2010 @ $57.49 0 Comment
TrackStanfordRes < 20 11/10/2008 Outperform NS $41.88 +37.27% +12.04% +25.23 6/9/2010 @ $57.49 0 Comment
TrackZacks < 20 5/29/2008 Outperform 3M $35.03 +15.13% -28.55% +43.68 10/7/2008 @ $40.33 1 Comment
TrackBMOCapital < 20 3/13/2008 Outperform NS $35.54 +61.76% -17.74% +79.50 6/9/2010 @ $57.49 0 Comment
TrackWellsFargo 90.44 3/3/2008 Outperform NS $37.18 +54.63% -19.92% +74.55 6/9/2010 @ $57.49 0 Comment
TrackUBS 91.99 1/4/2008 Outperform NS $45.63 +23.76% -21.30% +45.06 3/2/2010 @ $56.47 0 Comment
TrackBofASec 93.78 12/4/2007 Outperform NS $47.01 +22.29% -27.30% +49.59 6/9/2010 @ $57.49 0 Comment
TrackCollinsStew 75.84 11/30/2007 Outperform NS $47.25 +21.67% -28.42% +50.10 6/9/2010 @ $57.49 0 Comment
TrackLazardCapit 77.22 10/26/2007 Outperform NS $39.32 +46.21% -29.98% +76.19 6/9/2010 @ $57.49 0 Comment
TrackEdwardOwens 99.57 9/30/2007 Outperform NS $33.99 +69.14% -30.12% +99.26 6/9/2010 @ $57.49 3 Comments
TrackLehmanBros < 20 8/28/2007 Outperform NS $35.25 +26.33% -0.98% +27.30 1/3/2008 @ $44.53 0 Comment
TrackJPMorgan 90.81 8/14/2007 Outperform NS $32.00 +83.34% -18.46% +101.80 4/30/2010 @ $58.67 0 Comment
TrackZacks < 20 7/2/2007 Underperform 3M $36.44 -7.93% -3.72% +4.22 8/30/2007 @ $33.55 1 Comment
TrackPiperJaff 85.09 3/22/2007 Outperform NS $32.95 +74.48% -25.69% +100.17 6/9/2010 @ $57.49 0 Comment
TrackCitigroup 93.24 11/8/2006 Underperform NS $37.82 +52.01% -22.61% -74.61 6/9/2010 @ $57.49 0 Comment
TrackCollinsStew 75.84 10/27/2006 Outperform NS $39.71 -19.39% +6.72% -26.11 7/31/2007 @ $32.01 0 Comment
TrackLehmanBros < 20 10/26/2006 Underperform NS $38.75 -9.03% +5.19% +14.22 8/28/2007 @ $35.25 0 Comment

Featured Broker Partners